Abstract: . . .  and consumer input strengthens risk assessment and communication activities, as well as post-market policy development. GETTING THE WORD OUT • Risk information is made . . .
. . .  body, working together to develop guidelines/ recommendations for effective post-market surveillance of biotechnology products. • Expert scientific advice and consumer input . . .
. . .  sale in Canada, including those made from biotechnology , it is important to monitor these drugs and their effects while they are in widespread use. To meet this need, Health Canada has . . .
. . .  consumers are encour- aged to report any suspected adverse reaction for biotech- nology products to Health Canada. Page 3 HEALTH PROFESSIONALS AND . . .
. . .  WHAT ARE BIOLOGICALS AND BIOTECHNOLOGY PRODUCTS? • Biologicals are derived from living organisms or their parts, such as blood and its components derivatives,  . . .
. . .  products are relatively new in the field of thera- peutics, thus early detection of signals from adverse event data is important. THE MARKETED BIOLOGICS AND BIOTECHNOLOGY . . .
--1168,6,97,1592,5841